RNS Number:4566Q
Celsis International PLC
24 August 2005

                        BLOCK LISTING SIX MONTHLY RETURN



Information provided on this form must be typed or printed electronically.



To:  The FSA

 Date: 25 August 2005


AVS No:

Name of applicant:                                        CELSIS INTERNATIONAL PLC

Name of scheme:                                           UNAPPROVED SHARE SCHEME

Period of return:                          From:          19 MARCH 1997           To:        24 AUGUST 2005

Balance under scheme from previous return:                60,000

The amount by which the block scheme has been increased,  N/A
if the scheme has been increased since the date of the
last return:

Number of securities issued/allotted under scheme during  60,000
period:

Balance under scheme not yet issued/allotted at end of    0
period

Number and class of securities originally listed and the  110,000
date of admission

Total number of securities in issue at the end of the     112,415,218
period


Name of contact:                                           Christian Madrolle, Finance Director

Address of contact:                                        Suite 15, Lyndon House, Kings Court, Newmarket,  
                                                           Suffolk CB8 7SG

Telephone number of contact:                               01638 600 151



SIGNED BY   CHRISTIAN MADROLLE

Director/company secretary/suitably experienced employee/duly authorised officer,
for and on behalf of



CELSIS INTERNATIONAL PLC

Name of applicant



If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BLRZGGZRVDGGKZM

Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Celadon Pharmaceuticals Charts.